Log In
BCIQ
Print this Print this
 

Autologous fecal microbiota transplantation (MaaT001)

  Manage Alerts
Collapse Summary General Information
Company MaaT Pharma S.A.
DescriptionAutologous fecal microbiota transplantation
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard Indication Gastrointestinal (unspecified)
Indication DetailsPrevent dysbiosis; Treat cancer therapy-induced dysbiosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today